| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | 0 | 24.655 | 0 | 13.235 | 2.012 | 940 |
| Total Income - EUR | - | - | - | - | 0 | 24.968 | 8 | 13.446 | 2.055 | 968 |
| Total Expenses - EUR | - | - | - | - | 3.562 | 34.729 | 25.687 | 23.242 | 15.185 | 7.276 |
| Gross Profit/Loss - EUR | - | - | - | - | -3.562 | -9.761 | -25.679 | -9.796 | -13.130 | -6.308 |
| Net Profit/Loss - EUR | - | - | - | - | -3.562 | -10.004 | -25.679 | -10.028 | -13.130 | -6.308 |
| Employees | - | - | - | - | 0 | 1 | 1 | 1 | 0 | 0 |
Check the financial reports for the company - Miko Medsoon S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | 32.360 | 23.449 | 14.837 | 6.765 | 0 | 0 |
| Current Assets | - | - | - | - | 698 | 6.543 | 1.173 | 517 | 2.058 | 295 |
| Inventories | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | - | - | - | 0 | 0 | 0 | 27 | 0 | 0 |
| Cash | - | - | - | - | 698 | 6.543 | 1.173 | 491 | 2.058 | 295 |
| Shareholders Funds | - | - | - | - | -3.519 | -13.456 | -38.837 | -48.985 | -61.967 | -67.929 |
| Social Capital | - | - | - | - | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | - | 36.578 | 43.449 | 54.847 | 56.267 | 64.803 | 68.224 |
| Income in Advance | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4941 - 4941" | |||||||||
| CAEN Financial Year |
4941
|
|||||||||
Comments - Miko Medsoon S.r.l.